Bloodwork Before Starting Peptides: What Labs to Order

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Comprehensive bloodwork before starting peptide therapy is essential to establish a baseline, identify contraindications, and tailor the protocol for optimal safety and efficacy. Key labs include a complete metabolic panel, CBC, hormone levels, inflammatory markers, and specific tests relevant to the peptide's action.

The Foundation of Safe and Effective Peptide Therapy: Pre-Protocol Bloodwork

Initiating any peptide protocol without a thorough understanding of a patient's baseline physiological status is akin to navigating a ship without a compass. Comprehensive bloodwork is not merely a recommendation; it is a critical prerequisite for safe, effective, and individualized peptide therapy. It allows practitioners to identify pre-existing conditions, establish a baseline for monitoring, detect contraindications, and tailor the peptide regimen to the patient's unique needs.

Core Bloodwork Panel: The Essentials

Regardless of the specific peptide protocol, a foundational set of laboratory tests provides a broad overview of general health and metabolic function.

1. Complete Metabolic Panel (CMP)

The CMP assesses kidney function, liver function, electrolyte balance, and blood glucose levels.

• Kidney Function (BUN, Creatinine, eGFR): Peptides are metabolized and excreted, so healthy kidney function is important. Impaired function may necessitate dose adjustments.
• Liver Function (ALT, AST, ALP, Bilirubin): The liver metabolizes many substances. Baseline liver health is crucial, especially if combining peptides with other medications or supplements.
• Electrolytes (Sodium, Potassium, Chloride, CO2): Essential for cellular function.
• Glucose: Fasting glucose provides a baseline for metabolic health, particularly relevant for peptides influencing glucose regulation (e.g., GLP-1 agonists).

2. Complete Blood Count (CBC) with Differential

The CBC provides information about red blood cells, white blood cells, and platelets.

• Red Blood Cells (Hemoglobin, Hematocrit): Important for oxygen transport. Some peptides or concomitant therapies (e.g., TRT) can affect red blood cell mass.
• White Blood Cells: Indicators of immune function and potential underlying infection or inflammation.
• Platelets: Essential for clotting.

3. Lipid Panel

Measures cholesterol (total, LDL, HDL) and triglycerides. Provides insight into cardiovascular risk and metabolic health.

4. Thyroid Panel (TSH, Free T3, Free T4)

Thyroid hormones are central to metabolism, energy, and overall well-being. Dysregulation can impact the effectiveness of many peptide therapies.

Hormonal and Specific Biomarkers: Tailoring the Panel

Beyond the core panel, specific labs should be ordered based on the patient's symptoms, health goals, and the intended peptide protocol.

1. Growth Hormone (GH) Axis Peptides (e.g., Ipamorelin, CJC-1295)

• IGF-1 (Insulin-like Growth Factor 1): This is the primary biomarker for assessing growth hormone activity. A baseline IGF-1 is essential to track the efficacy of GH-releasing peptides. Typical healthy adult range is 100-300 ng/mL, but varies by age.
• Growth Hormone (GH): While pulsatile, a baseline random GH or a GH stimulation test can provide context, though IGF-1 is more stable.

2. Testosterone Optimization Peptides (e.g., Kisspeptin, Gonadorelin)

• Total Testosterone & Free Testosterone: Essential for assessing androgen status.
• Estradiol (E2), sensitive: To monitor estrogen levels, especially in men on TRT or those using peptides that might influence aromatization.
• Luteinizing Hormone (LH) & Follicle-Stimulating Hormone (FSH): To assess pituitary function and differentiate between primary and secondary hypogonadism.
• Prolactin: Can impact libido and fertility.

3. Metabolic Peptides (e.g., GLP-1 Agonists like Semaglutide, Tirzepatide)

• HbA1c: Long-term blood glucose control.
• Fasting Insulin: To assess insulin sensitivity.
• C-peptide: To assess endogenous insulin production.

4. Inflammatory Markers

• High-Sensitivity C-Reactive Protein (hs-CRP): A general marker of systemic inflammation. Relevant for peptides with anti-inflammatory properties (e.g., BPC-157, TB-500).
• Erythrocyte Sedimentation Rate (ESR): Another general inflammation marker.

5. Other Relevant Markers

• Vitamin D (25-hydroxyvitamin D): Crucial for immune function, bone health, and hormone regulation.
• Ferritin: Iron storage, important for energy and red blood cell production.
• Homocysteine: Marker for cardiovascular risk and methylation status.

Timing of Bloodwork

Bloodwork should ideally be drawn in the morning, after an overnight fast (typically 10-12 hours), to ensure consistency and accuracy, especially for glucose and lipid panels. For hormones, specific timing might be required (e.g., morning for testosterone).

Summary

Pre-protocol bloodwork is the cornerstone of responsible and effective peptide therapy. A comprehensive panel, including CMP, CBC, lipid panel, and thyroid hormones, provides a vital health overview. Additional specific markers, such as IGF-1 for GH-peptides or testosterone/estradiol for HPG-axis peptides, allow for precise protocol tailoring and monitoring. This data-driven approach ensures patient safety, optimizes therapeutic outcomes, and allows for proactive management of potential side effects or interactions.